India, Aug. 3 -- Today's top biotech gainers include Universe Pharmaceuticals, which recently filed its SEC report for the six months ended March 31, 2026; Cumberland Pharma, ahead of its second-quarter 2026 financial results due Tuesday; and Autolus Therapeutics, following the release of its preliminary quarterly results, among others.
Read on.
UPC Shrinks Loss
Universe Pharmaceuticals Inc. (UPC), a pharmaceutical producer and distributor in China, led the pack of gainers on Monday, with shares soaring nearly 100%.
An SEC filing dated July 29, 2026, shows the company's revenue was $9.03 million and net loss was $1.55 million or $2.76 per share, for the six months ended March 31, 2026. This compares with revenue of $9.15 million and a n...